$OMED Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoMed Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OncoMed Pharmaceuticals Inc. Get notifications about new insider transactions in OncoMed Pharmaceuticals Inc for free.
Page: < prev 1 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 172,437 | |
Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 23.00 | 1,500 | 34,500 | 20,896 | 22.4 K to 20.9 K (-6.70 %) |
Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 22,396 | 20.9 K to 22.4 K (+7.18 %) |
Jul 18 2014 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 20.46 | 4,000 | 81,853 | 101,532 | 105.5 K to 101.5 K (-3.79 %) |
Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 68,277 | |
Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 24.36 | 704 | 17,151 | 20,000 | 20.7 K to 20 K (-3.40 %) |
Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 23.75 | 3,296 | 78,283 | 20,704 | 24 K to 20.7 K (-13.73 %) |
Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
Jul 02 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 23.59 | 11,485 | 270,919 | 2,043,509 | 2.1 M to 2 M (-0.56 %) |
Jun 30 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 173,937 | |
Jun 30 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 23.00 | 1,500 | 34,503 | 20,896 | 22.4 K to 20.9 K (-6.70 %) |
Jun 30 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 22,396 | 20.9 K to 22.4 K (+7.18 %) |
Jun 27 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 23.56 | 3,252 | 76,624 | 2,054,994 | 2.1 M to 2.1 M (-0.16 %) |
Jun 25 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 23.57 | 11,764 | 277,320 | 2,058,246 | 2.1 M to 2.1 M (-0.57 %) |
Jun 25 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 24.20 | 52,797 | 1,277,429 | 2,070,010 | 2.1 M to 2.1 M (-2.49 %) |
Jun 20 2014 | OMED | OncoMed Pharmaceut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 25.95 | 15,000 | 389,250 | 15,000 | |
Jun 20 2014 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Option Exercise | A | 25.95 | 15,000 | 389,250 | 15,000 | |
Jun 20 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Option Exercise | A | 25.95 | 15,000 | 389,250 | 15,000 | |
Jun 20 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Option Exercise | A | 25.95 | 15,000 | 389,250 | 15,000 | |
Jun 20 2014 | OMED | OncoMed Pharmaceut ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 25.95 | 15,000 | 389,250 | 15,000 | |
Jun 20 2014 | OMED | OncoMed Pharmaceut ... | Lasky Laurence | Director | Option Exercise | A | 25.95 | 15,000 | 389,250 | 15,000 | |
Jun 20 2014 | OMED | OncoMed Pharmaceut ... | Gould Terry P | Director | Option Exercise | A | 25.95 | 15,000 | 389,250 | 15,000 | |
Jun 18 2014 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 24.99 | 4,000 | 99,965 | 105,532 | 109.5 K to 105.5 K (-3.65 %) |
Jun 17 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 72,277 | |
Jun 17 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 24.59 | 4,000 | 98,348 | 20,000 | 24 K to 20 K (-16.67 %) |
Jun 17 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
Jun 11 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | S | 24.48 | 1,614 | 39,511 | 11,123 | 12.7 K to 11.1 K (-12.67 %) |
Jun 11 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | S | 24.48 | 3,186 | 77,993 | 21,944 | 25.1 K to 21.9 K (-12.68 %) |
Jun 11 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | S | 24.62 | 2,776 | 68,345 | 15,513 | 18.3 K to 15.5 K (-15.18 %) |
Jun 11 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | S | 24.62 | 5,476 | 134,819 | 30,606 | 36.1 K to 30.6 K (-15.18 %) |
Jun 11 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | S | 24.48 | 1,614 | 39,511 | 11,123 | 12.7 K to 11.1 K (-12.67 %) |
Jun 11 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | S | 24.48 | 3,186 | 77,993 | 21,944 | 25.1 K to 21.9 K (-12.68 %) |
Jun 11 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | S | 24.62 | 2,776 | 68,345 | 15,513 | 18.3 K to 15.5 K (-15.18 %) |
Jun 11 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | S | 24.62 | 5,476 | 134,819 | 30,606 | 36.1 K to 30.6 K (-15.18 %) |
May 19 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | S | 22.51 | 28,956 | 651,800 | 0 | 29 K to 0 (-100.00 %) |
May 13 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Buy | J | 0.00 | 32,392 | 0 | 32,392 | 0 to 32.4 K |
May 13 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | J | 0.00 | 300,063 | 0 | 0 | 300.1 K to 0 (-100.00 %) |
May 13 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Buy | J | 0.00 | 300,063 | 0 | 300,063 | 0 to 300.1 K |
May 13 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | J | 0.00 | 9,421 | 0 | 28,261 | 37.7 K to 28.3 K (-25.00 %) |
May 13 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | J | 0.00 | 975,996 | 0 | 2,927,988 | 3.9 M to 2.9 M (-25.00 %) |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 28,956 | 0 | 28,956 | 0 to 29 K |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 9,307 | 0 | 9,307 | 0 to 9.3 K |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | S | 21.99 | 28,956 | 636,742 | 0 | 29 K to 0 (-100.00 %) |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 28,956 | 0 | 28,956 | 0 to 29 K |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | S | 21.98 | 17,371 | 381,815 | 17,382 | 34.8 K to 17.4 K (-49.98 %) |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 34,743 | 0 | 34,743 | 0 to 34.7 K |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 28,966 | 0 | 28,966 | 0 to 29 K |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | J | 0.00 | 300,063 | 0 | 0 | 300.1 K to 0 (-100.00 %) |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 300,063 | 0 | 300,063 | 0 to 300.1 K |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | J | 0.00 | 9,421 | 0 | 28,261 | 37.7 K to 28.3 K (-25.00 %) |
May 13 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | J | 0.00 | 975,996 | 0 | 2,927,988 | 3.9 M to 2.9 M (-25.00 %) |
May 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Option Exercise | M | 1.43 | 2,500 | 3,575 | 47,763 | |
May 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 26.41 | 2,500 | 66,019 | 49,343 | 51.8 K to 49.3 K (-4.82 %) |
May 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Buy | M | 1.43 | 2,500 | 3,575 | 51,843 | 49.3 K to 51.8 K (+5.07 %) |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Grant | A | 0.00 | 20,000 | 0 | 20,896 | 896 to 20.9 K (+2,232.14 %) |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Grant | A | 0.00 | 20,000 | 0 | 109,532 | 89.5 K to 109.5 K (+22.34 %) |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Grant | A | 0.00 | 22,500 | 0 | 23,575 | 1.1 K to 23.6 K (+2,093.02 %) |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Grant | A | 0.00 | 20,000 | 0 | 49,343 | 29.3 K to 49.3 K (+68.16 %) |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Patel Sunil | SVP & Chief Busines ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 1,792 | 0 | 82,928 | 81.1 K to 82.9 K (+2.21 %) |
Mar 27 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 1,792 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
Mar 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 35.81 | 1,792 | 64,180 | 29,343 | 31.1 K to 29.3 K (-5.76 %) |
Mar 12 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 81,136 | 0 | 81,136 | 0 to 81.1 K |
Mar 12 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Gift | G | 0.00 | 81,136 | 0 | 1,792 | 82.9 K to 1.8 K (-97.84 %) |
Mar 05 2014 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Buy | J | 0.00 | 576 | 0 | 804,270 | 803.7 K to 804.3 K (+0.07 %) |
Mar 05 2014 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Buy | J | 0.00 | 2,304 | 0 | 1,689,292 | 1.7 M to 1.7 M (+0.14 %) |
Feb 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Option Exercise | M | 1.43 | 5,000 | 7,150 | 50,263 | |
Feb 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 30.85 | 400 | 12,341 | 29,343 | 29.7 K to 29.3 K (-1.34 %) |
Feb 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 30.04 | 4,600 | 138,171 | 29,743 | 34.3 K to 29.7 K (-13.39 %) |
Feb 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Buy | M | 1.43 | 5,000 | 7,150 | 34,343 | 29.3 K to 34.3 K (+17.04 %) |
Oct 16 2013 | OMED | OncoMed Pharmaceut ... | WYZGA MICHAEL S | Director | Option Exercise | A | 14.00 | 27,853 | 389,942 | 27,853 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | MORGENTHALER PARTNERS VII LP | 10% Owner | Option Exercise | C | 0.00 | 893,825 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | MORGENTHALER PARTNERS VII LP | 10% Owner | Option Exercise | C | 0.00 | 834,732 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | MORGENTHALER PARTNERS VII LP | 10% Owner | Option Exercise | C | 0.00 | 710,526 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | MORGENTHALER PARTNERS VII LP | 10% Owner | Buy | P | 17.00 | 70,588 | 1,199,996 | 2,509,671 | 2.4 M to 2.5 M (+2.89 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | MORGENTHALER PARTNERS VII LP | 10% Owner | Buy | C | 0.00 | 893,825 | 0 | 2,439,083 | 1.5 M to 2.4 M (+57.84 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | MORGENTHALER PARTNERS VII LP | 10% Owner | Buy | C | 0.00 | 834,732 | 0 | 1,545,258 | 710.5 K to 1.5 M (+117.48 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | MORGENTHALER PARTNERS VII LP | 10% Owner | Buy | C | 0.00 | 710,526 | 0 | 710,526 | 0 to 710.5 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 1,166,150 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 1,441,396 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 1,166,150 | 0 | 2,607,546 | 1.4 M to 2.6 M (+80.90 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 1,441,396 | 0 | 1,441,396 | 0 to 1.4 M |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Option Exercise | C | 0.00 | 278,764 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Option Exercise | C | 0.00 | 666,661 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Option Exercise | C | 0.00 | 287,527 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Option Exercise | C | 0.00 | 547,205 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Option Exercise | C | 0.00 | 237,403 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Option Exercise | C | 0.00 | 473,122 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Buy | C | 0.00 | 278,764 | 0 | 803,694 | 524.9 K to 803.7 K (+53.10 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Buy | C | 0.00 | 287,527 | 0 | 524,930 | 237.4 K to 524.9 K (+121.11 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Buy | C | 0.00 | 237,403 | 0 | 237,403 | 0 to 237.4 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Buy | C | 0.00 | 666,661 | 0 | 1,686,988 | 1 M to 1.7 M (+65.34 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Buy | C | 0.00 | 547,205 | 0 | 1,020,327 | 473.1 K to 1 M (+115.66 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | VERTICAL GROUP LP | 10% Owner | Buy | C | 0.00 | 473,122 | 0 | 473,122 | 0 to 473.1 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 17,324 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 34,649 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 692,994 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 316,079 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 74,142 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 15,299 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 30,599 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 611,995 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 279,135 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 65,476 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 426,315 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | P | 17.00 | 1,080 | 18,360 | 33,703 | 32.6 K to 33.7 K (+3.31 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 17,324 | 0 | 32,623 | 15.3 K to 32.6 K (+113.24 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 15,299 | 0 | 15,299 | 0 to 15.3 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | P | 17.00 | 2,161 | 36,737 | 67,409 | 65.2 K to 67.4 K (+3.31 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 34,649 | 0 | 65,248 | 30.6 K to 65.2 K (+113.24 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 30,599 | 0 | 30,599 | 0 to 30.6 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | P | 17.00 | 43,223 | 734,791 | 1,348,212 | 1.3 M to 1.3 M (+3.31 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 692,994 | 0 | 1,304,989 | 612 K to 1.3 M (+113.24 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 611,995 | 0 | 611,995 | 0 to 612 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | P | 17.00 | 33,834 | 575,178 | 1,055,363 | 1 M to 1.1 M (+3.31 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 316,079 | 0 | 1,021,529 | 705.5 K to 1 M (+44.81 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 279,135 | 0 | 705,450 | 426.3 K to 705.5 K (+65.48 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 426,315 | 0 | 426,315 | 0 to 426.3 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | P | 17.00 | 7,937 | 134,929 | 247,555 | 239.6 K to 247.6 K (+3.31 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 74,142 | 0 | 239,618 | 165.5 K to 239.6 K (+44.81 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 65,476 | 0 | 165,476 | 100 K to 165.5 K (+65.48 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | LVP GP I, LLC | 10% Owner | Buy | C | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 14,527 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 7,051 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 13,910 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 1,505,032 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 11,731 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 5,694 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 11,233 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 1,215,407 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 9,926 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 4,817 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 9,505 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Option Exercise | C | 0.00 | 1,028,381 | 0 | 0 | |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | P | 17.00 | 1,498 | 25,466 | 37,682 | 36.2 K to 37.7 K (+4.14 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 14,527 | 0 | 36,184 | 21.7 K to 36.2 K (+67.08 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 11,731 | 0 | 21,657 | 9.9 K to 21.7 K (+118.18 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 9,926 | 0 | 9,926 | 0 to 9.9 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | P | 17.00 | 727 | 12,359 | 18,289 | 17.6 K to 18.3 K (+4.14 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 7,051 | 0 | 17,562 | 10.5 K to 17.6 K (+67.08 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 5,694 | 0 | 10,511 | 4.8 K to 10.5 K (+118.21 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 4,817 | 0 | 4,817 | 0 to 4.8 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | P | 17.00 | 1,434 | 24,378 | 36,082 | 34.6 K to 36.1 K (+4.14 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 13,910 | 0 | 34,648 | 20.7 K to 34.6 K (+67.07 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 11,233 | 0 | 20,738 | 9.5 K to 20.7 K (+118.18 %) |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | C | 0.00 | 9,505 | 0 | 9,505 | 0 to 9.5 K |
Jul 23 2013 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | P | 17.00 | 155,164 | 2,637,788 | 3,903,984 | 3.7 M to 3.9 M (+4.14 %) |